SEEMIN QURESHI: Open Payments
NPI 1871040071 · MILFORD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,022 in 39 payments from 9 companies in 2025. Trend: 2023 $1,697 · 2024 $1,829 · 2025 $1,022
Food & beverage: $971Education: $51
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 20 | $447 |
| Otsuka America Pharmaceutical, Inc. | 3 | $262 |
| ABBVIE INC. | 4 | $86 |
| Corium, LLC | 6 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $51 |
| Alkermes, Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Noven Therapeutics, LLC | 1 | $18 |
| Bausch Health US, LLC | 1 | $16 |
Products named: REXULTI, VRAYLAR, Azstarys, TRINTELLIX, ARISTADA, Auvelity, Xelstrym, APLENZIN.
Industry payments across MI — which companies pay providers there.
